Neuroprotection for Huntington’s Disease: Ready, Set, Slow
✍ Scribed by Steven M. Hersch; H. Diana Rosas
- Publisher
- Springer-Verlag
- Year
- 2008
- Tongue
- English
- Weight
- 110 KB
- Volume
- 5
- Category
- Article
- ISSN
- 1933-7213
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
jections 7 and single cell recording studies in putamen and pallidum of primates, 8 and also in humans during stereotaxic surgery. 9 Also, it is important in this differing topography that the changes in dopaminergic input into the striatum in Parkinson's disease affect the caudate and putamen in a
In the context of degenerative disorders of the basal ganglia, neuroprotective therapy refers to interventions that preserve the integrity and function of vulnerable neurons and thereby slow or halt clinical decline. Decoppering therapy for Wilson's disease is the only established neuroprotective th